331 related articles for article (PubMed ID: 15192709)
1. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
2. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
3. Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments.
Kachnic LA; Li L; Fournier L; Willers H
Cancer Lett; 2010 Jun; 292(1):73-9. PubMed ID: 20034732
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis.
Huber PA; Medhurst AL; Youssoufian H; Mathew CG
Biochem Biophys Res Commun; 2000 Feb; 268(1):73-7. PubMed ID: 10652215
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
8. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
9. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
[TBL] [Abstract][Full Text] [Related]
10. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
11. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
[TBL] [Abstract][Full Text] [Related]
12. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
13. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
[TBL] [Abstract][Full Text] [Related]
14. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
15. Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment.
Futaki M; Watanabe S; Kajigaya S; Liu JM
Biochem Biophys Res Commun; 2001 Feb; 281(2):347-51. PubMed ID: 11181053
[TBL] [Abstract][Full Text] [Related]
16. [Construction of FANCA mutant protein from Fanconi anemia patient and analysis of its function].
Chen F; Zhang KJ; Zuo XL; Zeng XC
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):741-4. PubMed ID: 18457264
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs.
Tamary H; Dgany O; Toledano H; Shalev Z; Krasnov T; Shalmon L; Schechter T; Bercovich D; Attias D; Laor R; Koren A; Yaniv I
Eur J Haematol; 2004 May; 72(5):330-5. PubMed ID: 15059067
[TBL] [Abstract][Full Text] [Related]
18. Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia.
González-Murillo A; Lozano ML; Alvarez L; Jacome A; Almarza E; Navarro S; Segovia JC; Hanenberg H; Guenechea G; Bueren JA; Río P
Hum Gene Ther; 2010 May; 21(5):623-30. PubMed ID: 20001454
[TBL] [Abstract][Full Text] [Related]
19. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
[TBL] [Abstract][Full Text] [Related]
20. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
